Skip to Content

CL 426 (Entecavir 0.5 mg)

Pill with imprint CL 426 is White, Three-sided and has been identified as Entecavir 0.5 mg. It is supplied by Cipla USA Inc..

Entecavir is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Entecavir 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 426

Entecavir 0.5 mg CL 426

Entecavir

Imprint
CL 426
Strength
0.5 mg
Color
White
Size
9.00 mm
Shape
Three-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0426
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, povidone, magnesium stearate, titanium dioxide, hypromellose 2910 (15 mPa.s), polyethylene glycol 6000

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.